Breakthroughs in Alzheimer’s research Subject : Science and technology Section: Health Concept : Less than two weeks after an Alzheimer’s drug developed by Biogen and Eisai won full approval from the US Food and Drug Administration (FDA), Eli Lilly’s monoclonal antibody donanemab has been shown to significantly slow the progression of the disease […]